Using Predictive Bioinformatics Algorithms for Difficult Neoantigen Peptide Synthesis for Precision Immuno-Oncology Development

Neoantigen based personalized immuno-oncology drugs are a relatively new therpauetic avenue that have shown strong anti-tumor efficacy in the clinic. Neoantigen peptides have been widely reported to be difficult to synthesize due to their hydrophobicity, length, and charge. Leveraging extensive peptide synthesis experience GenScript has developed NeoPre™, a predictive algorithm which is able to determine peptide synthesis difficulty based on sequence alone. NeoPre™ can then recommend the most efficient approach to successfully synthesizing peptides using one of GenScript's many synthesis platforms. This presentation will highlight how NeoPre™ identifies synthesis difficulty and review successful cases of difficult neoantigen peptide synthesis from several researchers.

Speaker-related Webinars

Neoantigen immunopeptidome profiling and production for personalized immuno-oncology therapeutic discovery

Neoantigen based immuno-oncology therapies are proving promising, but neoantigen identification and production are bottlenecks to boosting efficacy.

Learn More

Using Predictive Bioinformatics Algorithms for Difficult Neoantigen Peptide Synthesis for Precision Immuno-Oncology Development

Neoantigen based personalized immuno-oncology drugs are a relatively new therpauetic avenue that have shown strong anti-tumor efficacy in the clinic.

Learn More